Glucokinase (GCK) and other susceptibility genes for beta-cell dysfunction: the candidate approach.
There are well-documented examples in the literature of where determining the genetic aetiology of a disorder has provided insights into important regulatory pathways and protein interactions, and, more recently, has led to improved treatment options for patients. The studies of monogenic forms of b...
Huvudupphovsmän: | Gloyn, A, Tribble, N, van de Bunt, M, Barrett, A, Johnson, P |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
2008
|
Liknande verk
Liknande verk
-
Prevalence of glucokinase (GCK) mutations in people with elevated fasting glucose levels: implications for clinical trials
av: Gloyn, A, et al.
Publicerad: (2007) -
Identification and functional characterisation of novel inactivating glucokinase mutations causing GCK-MODY in Slovakia
av: Valentinova, L, et al.
Publicerad: (2011) -
Identification of a novel beta cell glucokinase (GCK) promoter mutation (-71 G > C) which reduces promoter activity
av: Gasperikova, D, et al.
Publicerad: (2008) -
Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation.
av: Christesen, H, et al.
Publicerad: (2008) -
Identification of a Novel beta-Cell Glucokinase (GCK) Promoter Mutation (-71G > C) That Modulates GCK Gene Expression Through Loss of Allele-Specific Sp1 Binding Causing Mild Fasting Hyperglycemia in Humans
av: Gasperikova, D, et al.
Publicerad: (2009)